Generics represent only 5.7% in value (approximately $4.6 billion) or 16.9% in volume in 2006 according to the IMS and the data from the Japanese Generics Manufacturing Association. In 2007, the Ministry of Finance announced a plan to double generic...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Teva and Kowa Announce Strategic Partnership to Create a Leading Generic Pharmaceutical Company in Japan
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account
account